UNASSIGNED:脊柱结核的标准推荐和常见的重建方法是钛网骨移植和自体髂骨。然而,这些方法都有自己的缺点。
UASSIGNED:为了评估一期后路清创术联合髂骨移植的临床疗效,钛网骨移植,或纳米羟基磷灰石/聚酰胺-66笼在胸椎和腰椎结核。
UNASSIGNED:在2013年1月至2018年12月期间,对57例胸腰椎结核患者在清创后行椎间植骨结合后路内固定治疗。13例患者采用髂骨移植构建稳定的椎体,26例患者接受钛网植骨治疗,18例患者接受纳米羟基磷灰石/聚酰胺66笼骨移植治疗。通过椎间高度评估主要临床结果,网箱沉降,操作时间,手术失血,术后住院,术后并发症,视觉模拟量表(VAS)评分,红细胞沉降率(ESR),C反应蛋白(CRP),美国脊柱损伤协会(ASIA)等级,和植骨融合时间。采用统计学方法对所有结果进行记录和分析。
UNASSIGNED:平均随访时间为24.5个月。在最后一次随访中,大多数患者的神经功能得到了改善。ESR存在显著差异,CRP,和术前和术后值之间的VAS评分;然而,ESR没有显着差异,CRP,三组的VAS评分。手术时间无明显差异,失血,术后住院,三组患者出院时的并发症情况。末次随访时,三组间ASIA分级差异无统计学意义。纳米羟基磷灰石/聚酰胺-66笼组的笼沉较低(P=0.013)。纳米羟基磷灰石/聚酰胺-66cage组的植骨融合时间明显短于髂骨植骨组和钛网骨植骨(P<0.05)。
UNASSIGNED:随访结果显示,该方法涉及一期后路清创和内固定,椎间移植,融合是胸腰椎结核患者安全有效的手术方法。在胸腰椎结核的手术治疗中,纳米羟基磷灰石/聚酰胺66cage与髂骨和钛网骨移植相比,cage骨沉降的发生率较低,植骨融合时间较短。纳米羟基磷灰石/聚酰胺66笼作为新型植骨材料具有广阔的应用前景。
UNASSIGNED: The standard recommended and common reconstruction method for spinal tuberculosis is titanium mesh bone graft and autogenous iliac crest. However, these methods have their own disadvantages.
UNASSIGNED: To evaluate the clinical efficacy of one-stage posterior debridement with iliac bone graft, titanium mesh bone graft, or nanohydroxyapatite/polyamide-66 cage in thoracic and lumbar tuberculosis.
UNASSIGNED: Between January 2013 and December 2018, 57 patients with thoracic or lumbar tuberculosis were treated by interbody bone graft combined with posterior internal fixation after debridement. Thirteen patients were treated with iliac bone graft to construct the stability of the vertebral body, 26 patients were treated with titanium mesh bone graft, and 18 patients were treated with nanohydroxyapatite/polyamide-66 cage bone graft. The main clinical results were evaluated by intervertebral height, cage subsidence, operation time, operative blood loss, postoperative hospitalization, postoperative complications, visual analog scale (VAS) score, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), American Spinal Injury Association (ASIA) grade, and bone graft fusion time. All the outcomes were recorded and analyzed by statistical methods.
UNASSIGNED: The mean follow-up time was 24.5 months. Neurologic function was improved in most patients at the last follow-up. There were significant differences in ESR, CRP, and VAS score between preoperative and postoperative values; however, there were no significant differences in ESR, CRP, and VAS score among the three groups. There were no significant differences in operation time, blood loss, postoperative hospitalization, and postoperative complications among the three groups at discharge. There was no significant difference in ASIA grade among the three groups at the last follow-up. Nanohydroxyapatite/polyamide-66 cage group had a lower cage subsidence (P = 0.013). The bone graft fusion time of the nanohydroxyapatite/polyamide-66 cage group was significantly shorter than the iliac bone graft group and the titanium mesh bone graft (P < 0.05).
UNASSIGNED: The follow-up outcomes showed that the method involving one-stage posterior debridement and internal fixation, interbody graft, and fusion is an effective and safe surgical method for patients with thoracic and lumbar tuberculosis. The incidence rate of cage subsidence was less and the bone graft fusion time was shorter with nanohydroxyap atite/polyamide 66 cage when compared with iliac bone graft and titanium mesh bone graft in the surgical treatment of thoracic and lumbar tuberculosis. Nanohydroxyapatite/polyamide-66 cage has a promising application prospect to be a new bone graft material.